Skip to content

Microbial biochemistry and pathogenesis

Specialized Group:

Miguel A. Valvano, MD. Professor of Microbiology and Infectious Diseases

Centre for Infection and Immunity, Queen’s University Belfast, Belfast, United Kingdom

m.valvano@qub.ac.uk

What do we do?

Our research involves an interdisciplinary approach using molecular genetics, biochemistry, cell biology, and structural biology to understand the pathogenesis of Gram-negative bacteria at the molecular level. Burkholderia cenocepacia, Escherichia coli, Salmonella enterica, and Shigella flexneri are the model organisms we use in different aspects of our research program.

Why is it important?

Opportunistic infections pose a significant threat to human health, especially to those patients who benefit most from advancements in the treatment of genetic diseases, cancer, and organ transplantation, but who become immunosuppressed. Burkholderia cepacia complex bacteria (Bcc) and Burkholderia cenocepacia in particular are our main model organisms to study the pathogenicity of opportunistic bacteria. Bcc bacteria are a major health risk for children and young adults with genetic conditions like cystic fibrosis and chronic granulomatous disease. These patients commonly suffer from lung and airways infections by these microorganisms, which are very difficult to treat given the extraordinary resistance of these bacteria to clinically useful antimicrobials. Therefore, through out research we hope to find novel ways to prevent or ameliorate the effect of these infections in susceptible patients.

Enteric bacteria such as Escherichia coli, Salmonella, and Shigella are also important human pathogens, which are particularly endemic in certain parts of the world. Lipopolysaccharide (LPS) is a complex glycolipid molecule located on the surface of Gram-negative bacteria that is also a critical structural component of the bacterial outer membrane. Bacteria with defects in the LPS molecule are more sensitive to a variety of antibiotics and they can be easily killed by host defensive mechanisms such as the serum complement and antimicrobial peptides. Therefore, by understanding how the LPS is made and assembled on the bacterial cell surface we hope to design inhibitors that will interfere with this process, which may be useful as novel antimicrobials. Also, we are looking at ways to alter LPS biosynthesis at various levels to increase the overall permeability of the outer membrane to antibiotics and antimicrobial peptides. What we learn in Escherichia coli, Salmonella enterica, and Shigella flexneri is also applied to Burkholderia cenocepacia.

Examples of key questions we currently investigate

We discovered that genetic ablation of LPS synthesis or chemical inhibitors of certain LPS biosynthesis enzymes can “weaken” the bacterial outer membrane and facilitate the entry of conventional antibiotics and antimicrobial peptides, especially in B. cenocepacia and other Bcc bacteria. We have also conducted detailed studies on proteins required for the synthesis of core oligosaccharide and O antigen moieties of the LPS molecules. These components are crucial for the virulence of E. coli, Salmonella, and Shigella. Now we want to learn:

How LPS components are synthesized?

What are the mechanistic bases of the translocation of O-antigen LPS biosynthesis intermediates across the plasma membrane?

How Bcc bacteria can survive the attack of antimicrobial cationic peptides and other antibiotics?

We discovered that Bcc bacteria survive intracellularly in free-living amoebae and macrophages by altering the maturation of the phagosome, and this research has led to the hypothesis that these cells become a reservoir for the persistence and dissemination of these bacteria in the host. We have also discovered a novel secretory system in B. cenocepacia (type VI) that appears to alter the cytoskeleton of infected macrophages and is required for infection in an animal model of chronic lung infection. Now we want to learn:

How does intracellular B. cenocepacia delay phagosome maturation and phagosomal acidification?

What is the role of a novel type 6-secretion system in B. cenocepacia intracellular survival?

How does intracellular B. cenocepacia affect the assembly of the macrophage NADPH oxidase?

We discovered several master regulators that respond to different types of stress. Mutations in the genes encoding these regulators impair the ability of B. cenocepacia to survive within macrophages and also in the animal model of chronic lung infection. We have observed that antioxidant bacterial defenses are critical for intracellular survival. Now we want to learn:

How does B. cenocepacia adapt to various environments including macrophage and epithelial cells?

What are the roles of stress regulators in intracellular survival and in bacterial survival in the rat model of chronic lung infection?

How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways?

How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways?

Representative bibliography

How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways? How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways? Burkholderia cenocepacia How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways?

How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways? How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways? Burkholderia cenocepacia and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press.

and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press. and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press.

and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press. and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press. Burkholderia cenocepacia and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press.

and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press. How do bacterial antioxidant mechanisms protect essential bacterial metabolic pathways that are deemed to be critical for adaptation to different environments, including the lung and airways? Burkholderia cenocepacia and other multi antibiotic resistant Gram-negative bacteria. In Host-bacteria interactions: Methods and Protocols, pp. 311-327. Edited by Vergunst A y Callaghan D O: Human Press.

Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA. Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA. Burkholderia cenocepacia Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA.

Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA. Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA. Burkholderia cenocepacia Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA.

Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA. Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA. Burkholderia cenocepaciaSchmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA.

Schmerk CL, Welander PV, Hamad MA, Bain KL, Bernards MA, Summons RE and Valvano MA. (2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Burkholderia cenocepacia(2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in

(2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in (2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Escherichia coli and Caulobacter crescentus(2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in

(2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in (2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Burkholderia cenocepacia (2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in

(2012). Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in (2010). Membrane topology and identification of critical amino acid residues in the Wzx O-antigen translocase from Escherichia coli (2010). Membrane topology and identification of critical amino acid residues in the Wzx O-antigen translocase from

http://publish.uwo.ca/~mvalvano/index.html

Play Video

Privacy Policy

This website is owned by the SPANISH SOCIETY OF MICROBIOLOGY, whose identification data are the following:

  • Center for Biological Research (CIB-CSIC)
  • c / Ramiro de Maeztu, 9 28040 Madrid.
  • Phone. 91 561 33 81 - Fax. 91 561 32 99
  • National Registry of Associations with the national number 579
  • CIF: G28648871

1. INFORMATION AND CONSENT.

By accepting this Privacy Policy, the User is informed and gives their free, informed, specific and unequivocal consent so that the personal data provided through this website (hereinafter, the "Website") are processed by SEM.

2. OBLIGATORY TO PROVIDE THE DATA.

The data requested in the web forms are generally mandatory (unless otherwise specified in the required field) to fulfill the established purposes. Therefore, if they are not provided or are not provided correctly, they will not be able to be attended to, without prejudice to the fact that you can freely view the content of the Website.

3. FOR WHAT PURPOSE WILL THE USER'S PERSONAL DATA BE PROCESSED AND FOR HOW LONG?

The personal data provided through the Website will be processed by SEM in accordance with the following purposes:

  • Manage and process the registration requests of new members, from the "new members" forms, as well as manage the fees and derived charges.
  • Periodically send members, including by electronic means, information, events or news that may be of interest to them, if the future member gives their consent by checking the corresponding check box, or, where appropriate, opposes or revokes their consent.

4. WHAT USER DATA WILL BE PROCESSED?

SEM will process the following categories of User data:

  • Identification data: name, surname and ID.
  • Contact information: postal address, email address and telephone.
  • Professional data: workplace and professional contact details.
  • Academic data: degree and specialization.
  • Billing information.

5. WHAT IS THE LEGITIMATION OF THE PROCESSING OF USER DATA?

The treatment of the User's data by the SEM is based on the consent that is requested and that you can withdraw at any time. However, in case of withdrawing your consent, this will not affect the legality of the treatments carried out previously.
The consents obtained for the aforementioned purposes are independent so that the User may revoke only one of them, not affecting the others.

6. TO WHICH RECIPIENTS WILL THE USER DATA BE COMMUNICATED?

The data of the partners may be communicated to the following companies in the cases indicated:

• To the corresponding banking entities in order to manage the collection of direct debit bills.

The User's data will not be communicated to any other entity, except legal obligation.

7. RESPONSIBILITY OF THE USER.

The User and the Candidate for membership:
- Guarantees that you are over 18 years of age and that the data you provide to the SEM is true, accurate, complete and updated. For these purposes, the User is responsible for the veracity of all the data that he communicates and will keep the information provided suitably updated, in such a way that it responds to his real situation.
- You will be responsible for the false or inaccurate information that you provide through the Website and for the direct or indirect damages that this causes to the SEM or to third parties.

8. COMMUNICATIONS.

One of the purposes for which the SEM processes the personal data provided by Users is to send them electronic communications with information related to congresses and other events, grant programs, scientific dissemination, awards or relevant news for the recipients.
In the event that the recipient wishes to stop receiving informative communications from the SEM, they can request the cancellation of the service by sending an email to secretaria.sem@semicrobiologia.com or by clicking on the "unsubscribe" link included in the communications.

9. EXERCISE OF RIGHTS.

The User can send a letter at any time and free of charge to the SEM, Centro de Investigaciones Biológicas (CIB-CSIC) - c / Ramiro de Maeztu, 9 28040 Madrid, attaching a photocopy of their identity document, to request their rights of access, rectification, deletion, opposition, limitation, portability of your data.
You can also complain to the Spanish Agency for Data Protection, through the following address: Spanish Agency for Data Protection, C / Jorge Juan, 6, 28001-Madrid, when the interested party considers that the SEM has violated the rights that They are recognized by the applicable regulations on data protection.

10. SECURITY MEASURES.

The SEM will treat the data of Users, Candidates and Partners at all times in an absolutely confidential manner and keeping the mandatory duty of secrecy regarding them, in accordance with the provisions of the applicable regulations, adopting technical measures and measures for this purpose. necessary organizational measures that guarantee the security of your data and prevent its alteration, loss, treatment or unauthorized access, taking into account the state of technology, the nature of the stored data and the risks to which they are exposed.

(2010). Membrane topology and identification of critical amino acid residues in the Wzx O-antigen translocase from